Impulsive and compulsive behaviors in Parkinson's disease

Area of Science:

• Neurology
• Neuroscience
• Psychiatry

Background:

• Impulsive-compulsive behaviors (ICBs) are a significant adverse effect of dopamine replacement therapy in Parkinson's disease (PD).
• Understanding the underlying mechanisms and risk factors for ICBs in PD is crucial for patient well-being.
• Previous research has focused on the link between dopamine therapy and ICBs, but the motivational aspects require further clarification.

Purpose of the Study:

• To review the phenomenology, prevalence, and risk factors associated with ICBs in Parkinson's disease.
• To explore the motivational underpinnings of ICBs, moving beyond hedonistic explanations.
• To discuss recent findings from functional imaging studies and provide therapeutic guidelines for managing ICBs in PD.

Main Methods:

• Literature review of studies on ICBs in Parkinson's disease.
• Analysis of behavioral studies assessing the neuropsychological profile of PD patients.
• Inclusion of insights from functional imaging studies investigating the incentive salience hypothesis.

Main Results:

• ICBs in Parkinson's disease are not primarily driven by hedonistic motivation.
• Factors such as difficulty coping with uncertainty may trigger ICBs in PD patients.
• Functional imaging studies support the incentive salience hypothesis in the context of PD-related ICBs.

Conclusions:

• ICBs in Parkinson's disease represent a complex behavioral addiction with non-hedonistic drivers.
• The inability to cope with uncertainty is a potential trigger for ICBs.
• Current understanding supports the incentive salience hypothesis, informing therapeutic strategies for managing ICBs in PD.